Burgac Ezgi, Yılmaz Sonay Duran, Bulut Fatma Derya, Kor Deniz, Kara Esra, Köseci Burcu, Kaplan İrem, Seydaoğlu Gülşah, Mert Gülen Gül, Mungan Neslihan Önenli
Cukurova University, Department of Pediatric Metabolism, Adana, Turkey.
Cukurova University, Department of Pediatrics, Adana, Turkey.
Eur J Paediatr Neurol. 2025 Jul;57:50-56. doi: 10.1016/j.ejpn.2025.05.011. Epub 2025 May 31.
Cystinosis is a lysosomal storage disease resulting from impaired transport of cystine due to variants in CTNS gene. Cystine accumulation leads to renal, corneal, and endocrine involvements. Patients typically present with growth retardation, polyuria/polydipsia, rickets. However, neurological manifestations are rare and become more pronounced with increasing age.
Fifty-one patients with cystinosis were evaluated using cerebral magnetic resonance imaging, electroneuromyography, audiological and psychometric tests.
The mean age of the patients was 164.8 ± 112.4 months. The common symptoms were failure to thrive (56.9 %), polyuria/polydipsia (45.1 %), and short stature (37.3 %). Renal, endocrine, ocular, and neurological involvement was present in 100 %, 78.4 %, 76.5 %, and 49 % of patients, respectively. Abnormal magnetic resonance imaging findings were observed in three patients. Psychometric tests were performed in 20 patients. Four patients had borderline intelligence, two had mild, four had moderate, and two had severe intellectual disability. Eight patients had delays in personal-social, fine/gross motor, and language development. Two of 29 patients who underwent audiological evaluation were found to have hearing loss. Three patients had neuropathy, one had myopathy. One patient had epilepsy. There was no significant difference in cystine levels between the patients with and without neurological involvement.
Compared to literature, our study appears to be a case series in which mental affect was reported the most. This effect may be due to frequent hospitalization, lack of stimulation, sociocultural status of the family and cortical atrophy in patients with chronic renal disease. Hearing loss was first reported in our study, regardless of audiotoxic drug usage.
胱氨酸病是一种溶酶体贮积病,由CTNS基因突变导致胱氨酸转运受损引起。胱氨酸蓄积会导致肾脏、角膜和内分泌系统受累。患者通常表现为生长发育迟缓、多尿/烦渴、佝偻病。然而,神经学表现较为罕见,且随着年龄增长会更加明显。
对51例胱氨酸病患者进行了脑磁共振成像、神经电生理检查、听力检查和心理测试。
患者的平均年龄为164.8±112.4个月。常见症状为生长发育不良(56.9%)、多尿/烦渴(45.1%)和身材矮小(37.3%)。肾脏、内分泌、眼部和神经受累的患者分别占100%、78.4%、76.5%和49%。3例患者磁共振成像检查结果异常。对20例患者进行了心理测试。4例患者智力临界,2例轻度智力残疾,4例中度智力残疾,2例重度智力残疾。8例患者在个人社交、精细/粗大运动和语言发育方面存在延迟。29例接受听力检查的患者中有2例听力丧失。3例患者患有神经病变,1例患有肌病。1例患者患有癫痫。有神经受累和无神经受累的患者之间胱氨酸水平无显著差异。
与文献相比,我们的研究似乎是报道精神影响最多的病例系列。这种影响可能是由于慢性肾病患者频繁住院、缺乏刺激、家庭的社会文化状况以及皮质萎缩所致。无论是否使用耳毒性药物,听力丧失在我们的研究中首次被报道。